Local Storage seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Local Storage in your browser.

Please make sure you are on the webshop of your country due to certain limitations on products. Click here

Optimmune-canis 3,5 g

Expiry date:
Ciclosporine A 0,2 % (2,0 mg/g) to treat chronic keratoconjunctivitis sicca and chronic superficial keratitis in dogs
More info

Optimmune is a white petrolatum based ointment for ophthalmic use, containing 0.2% w/w cyclosporin Ph. Eur.


Cyclosporin is an immunosuppressant with lacrimomimetic and anti-inflammatory properties.In the dog, Optimmune is indicated for the treatment of chronic recurrent conjunctivitis resulting from auto-immune disease of the eye. Optimmune is indicated for the therapeutic treatment of keratoconjunctivitis sicca (KCS, `dry eye') and chronic superficial keratitis (`pannus'). Optimmune may be used to augment topical corticosteroids or as a substitute for corticosteroids when these are contraindicated by corneal ulceration.
Dosage and administration

For topical administration to the conjunctival sac. Apply a small amount of ointment (approximately 1/4 inch or 1/2 cm) into the affected eye(s) every 12 hours.
Any excessive discharge in the eye should be removed prior to application of the ointment by gently cleansing or flushing the eye with a suitable non-irritating solution.
Duration of treatment
Clinical experience suggests that 90% of dogs affected with KCS will require life-long therapy. However, if therapy is maintained the prognosis is good providing that regular clinical assessment is carried out. Current experience suggests that, in the treatment of `pannus', the frequency of application of Optimmune may be suspended or reduced during certain periods of the year when levels of ultraviolet light, which exacerbates this condition, are reduced.
Ciclosporine A 0,2 %
© 2022 Grovet B.V. All rights reserved.